Abstract
A series of hinge-binder tethered 1,2,3-triazolylsalicylamide derivatives were designed, synthesized, and evaluated for the Aurora kinase inhibitory activities. The novel hinge-binder tethered 1,2,3-triazolylsalicylamide scaffold was effectively assembled by Cu(I)-catalyzed azide-alkyne 1,3-dipolar cycloaddition (CuAAC). A variety of alkynes with hinge binders were used to search proper structures-binding relationship to the hinge region. The synthesized 1,2,3-triazolylsalicylamide derivatives showed significant Aurora kinase inhibitory activity. In particular, 8a inhibited Aurora A kinase with an IC50 value of 0.284 μM, whereas 8m inhibited Aurora B kinase with an IC50 value of 0.364 μM.
Original language | English |
---|---|
Pages (from-to) | 2114-2124 |
Number of pages | 11 |
Journal | Bioorganic and Medicinal Chemistry |
Volume | 24 |
Issue number | 9 |
DOIs | |
State | Published - 1 May 2016 |
Bibliographical note
Funding Information:This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF- 2015R1A2A2A01004511 ).
Publisher Copyright:
© 2016 Elsevier Ltd. All rights reserved.
Keywords
- 1,2,3-Triazole
- Anticancer
- Aurora kinase
- Click chemistry
- Hinge-binder